Cancer Risk and Surveillance in Primary Sclerosing Cholangitis

被引：41
|
作者：
Folseraas, Trine [1 ,2 ,3 ]
Boberg, Kirsten Muri [1 ,2 ,3 ]
机构：
[1] Oslo Univ Hosp, Rikshosp, Div Canc Med Surg & Transplantat, Dept Transplantat Med,Gastroenterol Sect, N-0424 Oslo, Norway
[2] Oslo Univ Hosp, Rikshosp, Div Canc Med Surg & Transplantat, Norwegian PSC Res Ctr,Dept Transplantat Med, N-0424 Oslo, Norway
[3] Univ Oslo, Rikshosp, Inst Clin Med, N-0027 Oslo, Norway
来源：
CLINICS IN LIVER DISEASE | 2016年 / 20卷 / 01期
关键词：
Primary sclerosing cholangitis; Carcinoma; Dysplasia; Cholangiocarcinoma; Inflammatory bowel disease; Surveillance; Brush cytology; INFLAMMATORY-BOWEL-DISEASE; IN-SITU HYBRIDIZATION; DOSE URSODEOXYCHOLIC ACID; POPULATION-BASED COHORT; ULCERATIVE-COLITIS; LIVER-TRANSPLANTATION; COLORECTAL-CANCER; NATURAL-HISTORY; BRUSH CYTOLOGY; CLINICAL PRESENTATION;
D O I：
10.1016/j.cld.2015.08.014
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Primary sclerosing cholangitis (psq is a chronic, progressive disease characterized by inflammatory and fibrosing strictures of the biliary tree. PSC is associated with a high lifetime risk of hepatobiliary and colorectal cancers. The nature of the carcinogenic process in PSC is not well established. The lack of diagnostic methods for early detection and the limited therapeutic options for cholangiocarcinoma constitute a major challenge in the current handling of PSC patients. The article reviews the risk for cancer development in PSC and discusses surveillance strategies for PSC-associated cancers.
引用
收藏
页码：79 / +
页数：21
相关论文
共 50 条
  • [1] Cancer risk, screening and surveillance in primary sclerosing cholangitis
    Chascsa, David M.
    Lindor, Keith D.
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2019, 65 (03) : 214 - 228
  • [2] An update on cancer risk and surveillance in primary sclerosing cholangitis
    Horsley-Silva, Jennifer L.
    Rodriguez, Eduardo A.
    Franco, Diana L.
    Lindor, Keith D.
    LIVER INTERNATIONAL, 2017, 37 (08) : 1103 - 1109
  • [3] Surveillance for Hepatobiliary Cancer in Primary Sclerosing Cholangitis
    Nasser-Ghodsi, Navine
    Ali, Ahmad
    Hilscher, Moira
    Carey, Elizabeth J.
    Lindor, Keith D.
    Tabibian, James
    HEPATOLOGY, 2016, 64 : 664A - 664A
  • [4] Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
    Fung, Brian M.
    Lindor, Keith D.
    Tabibian, James H.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (06) : 659 - 671
  • [5] Cancer Surveillance in Patients With Primary Sclerosing Cholangitis
    Razumilava, Nataliya
    Gores, Gregory J.
    Lindor, Keith D.
    HEPATOLOGY, 2011, 54 (05) : 1842 - 1852
  • [6] Cancer risk in primary sclerosing cholangitis: Epidemiology,prevention, and surveillance strategies
    Brian M Fung
    Keith D Lindor
    James H Tabibian
    World Journal of Gastroenterology, 2019, (06) : 659 - 671
  • [7] Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance
    Ehlken, Hanno
    Zenouzi, Roman
    Schramm, Christoph
    CURRENT OPINION IN GASTROENTEROLOGY, 2017, 33 (02) : 78 - 84
  • [8] Surveillance and Screening of Primary Sclerosing Cholangitis
    El Fouly, Amr
    Dechene, Alexander
    Gerken, Guido
    DIGESTIVE DISEASES, 2009, 27 (04) : 526 - 535
  • [9] How Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed?
    Ehlken, Hanno
    Schramm, Christoph
    VISZERALMEDIZIN, 2015, 31 (03): : 173 - 177
  • [10] Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk
    Nanjundappa, Roopa H.
    Christen, Urs
    Umeshappa, Channakeshava S.
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (09)
12345